Study provides valuable insights into the DCB-only strategy for left main coronary artery disease

Sanna Uskela et al., at North Karelia Central Hospital-Heart Center, Finland, conducted a retrospective single-center registry study that focused on the use of drug-coated balloon (DCB)-only strategy for treating de novo left main coronary artery disease.

CEPI and WHO call for urgent global research to prepare for the next pandemic

The Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO) today called on researchers and governments to strengthen and accelerate global research

August 2, 2024

‘Attack JAK’: Ajax secures $95M to test new JAK2 inhibitor after industry’s string of myelofibrosis deals

A large pharma company wanted to buy Ajax Therapeutics when it was raising a $40 million Series B in 2021. But the startup thought it

May 14, 2024

Ivermectin Suit Revived; Curbing Fentanyl Deaths in Kids; Medicare Spending Plateau

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Doctors’ Ivermectin Lawsuit Revived Last week,

September 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.